Siemens healthcare diagnostics inc.Has investigated the cause of the discordant activated partial thromboplastin time (aptt) patient results generated on the sysmex ca-620 system and determined that the differences observed for the aptt in seconds between the 2 labs can be further explained by a difference in the systems and lot numbers of reagents being used.As stated in the reagent instructions for use, results should be related to the normal range in each laboratory.Reference intervals vary from laboratory to laboratory depending on the population served and the technique, method, equipment and reagent lot used.The aptt results are within the respective normal ranges for each lab.Siemens determined that there is no evidence of a reagent, instrument or software malfunction.The customer service engineer (cse) adjusted the detector well temperature and ran quality control (qc) without issue.The differences observed between the aptt results between the labs is potentially due to the difference in systems and reagent lots used.No further evaluation of this device is required.The systems and reagents are performing according to specifications.Mdr 9610806-2018-00055 was filed for the pt patient results using dade innovin lot 539388.
|
Multiple discordant prothrombin time (pt) patient sample results were generated on a sysmex ca-620 system (serial number (b)(4)) and reported to physicians using dade innovin lot 539388 when quality control (qc) for pt was out of range.Some patient samples were run for activated partial thromboplastin time (aptt) using dade actin fsl activated ptt reagent lot 556912.On the following day ((b)(6) 2018), all patient samples were retested at an alternate laboratory on a sysmex cs-2500 system, using dade innovin lot 549704 and dade actin fsl activated ptt reagent lot 556904.No corrected reports were issued to physicians.There are no reports of patient intervention or adverse health consequences due to the differences in aptt results between the two laboratories.
|